DanCann Pharma A/S publishes Year-end report for 2020
COPENHAGEN, Denmark, 26 February 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) today releases its results for the period 1 January – 31 December 2020. The Year-end report is available as an attached document to this press release and on www.dancann.com.Fourth quarter 2021 (1 October – 31 December) · Net sales was KDKK 0 (0) · Operating profit (EBIT) was -2,721 (-493) · Result per share (DKK) was -0.07 (-460,000)* · Equity ratio was 0.89 (-0.42) Full year 2020 (1 January – 31 December) · Net sales was KDKK 0 (0) · Operating profit (EBIT)